Phase 2, open-label, 1:1 randomized controlled trial exploring the efficacy of EMD 1201081 in combination with cetuximab in second-line cetuximab-naïve patients with recurrent or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN)
Ruzsa, A., Sen, M., Evans, M., Lee, L. W., Hideghety, K., Rottey, S., Klimak, P., Holeckova, P., Fayette, J., Csoszi, T., Erfan, J., Forssmann, U., Goddemeier, T., Bexon, A., Nutting, C.
Published in Investigational new drugs (01.12.2014)
Published in Investigational new drugs (01.12.2014)
Get full text
Journal Article
Phase I dose expansion data for M6620 (formerly VX-970), a first-in-class ATR inhibitor, combined with gemcitabine (Gem) in patients (pts) with advanced non-small cell lung cancer (NSCLC)
Plummer, R., Cook, N., Arkenau, T., Melear, J., Redfern, C., Spira, A.I., Chung, K., Haddad, T., Ramalingam, S.S., Wesolowski, R., Dean, E., Goddemeier, T., Falk, M., Shapiro, G.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Prognostic factors in patients with advanced non-small cell lung cancer: Data from the phase III FLEX study
Pirker, R, Pereira, J.R, Szczesna, A, von Pawel, J, Krzakowski, M, Ramlau, R, Vynnychenko, I, Park, K, Eberhardt, W.E.E, de Marinis, F, Heeger, S, Goddemeier, T, O’Byrne, K.J, Gatzemeier, U
Published in Lung cancer (Amsterdam, Netherlands) (01.08.2012)
Published in Lung cancer (Amsterdam, Netherlands) (01.08.2012)
Get full text
Journal Article
9019 POSTER DISCUSSION Safety Analysis of Patient Subgroups Defined by Low and High Tumour Epidermal Growth Factor Receptor (EGFR) Expression in FLEX Study Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) Receiving Chemotherapy With or Without Cetuximab as First-Line Therapy
von Pawel, J, Pirker, R, Pereira, J.R, Krzakowski, M, Park, K, Eberhardt, W.E.E, Schnaars, Y, Heeger, S, Goddemeier, T, Paz-Ares, L
Published in European journal of cancer (1990) (2011)
Published in European journal of cancer (1990) (2011)
Get full text
Journal Article
1437PPhase I dose expansion data for M6620 (formerly VX-970), a first-in-class ATR inhibitor, combined with gemcitabine (Gem) in patients (pts) with advanced non-small cell lung cancer (NSCLC)
Plummer, R, Cook, N, Arkenau, T, Melear, J, Redfern, C, Spira, A I, Chung, K, Haddad, T, Ramalingam, S S, Wesolowski, R, Dean, E, Goddemeier, T, Falk, M, Shapiro, G
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Phase IB Trial of Imo-2055 in Combination with 5-Fu, Cisplatin and Cetuximab in 1st-Line PTS with Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck (R/M SCCHN)
Machiels, J.P., Kaminsky, M.C., Keller, U., Brümmendorf, T.H., Goddemeier, T., Forssman, U., Delord, J.P.
Published in Annals of oncology (01.09.2012)
Published in Annals of oncology (01.09.2012)
Get full text
Journal Article
1044P - Phase IB Trial of Imo-2055 in Combination with 5-Fu, Cisplatin and Cetuximab in 1st-Line PTS with Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck (R/M SCCHN)
Machiels, J.P., Kaminsky, M.C., Keller, U., Brümmendorf, T.H., Goddemeier, T., Forssman, U., Delord, J.P.
Published in Annals of oncology (01.09.2012)
Published in Annals of oncology (01.09.2012)
Get full text
Journal Article
Simple-to-use, reference criteria for revealing drug-induced QT interval prolongation in conscious dogs
Schmitt, Michael W., Von Landenberg, Friedrich, Poth, Hartmut, Wimmer, Elmar, Goddemeier, Thomas, Cavero, Icilio
Published in European journal of pharmacology (05.01.2007)
Published in European journal of pharmacology (05.01.2007)
Get full text
Journal Article
Breast feeding studies 1981-1983 in 1,500 mothers in Dortmund and Haltern. III. Rates of breast feeding and duration of breast feeding in the first half year
Kersting, M, Wember, T, Goddemeier, T, Koester, H, Wennemann, J, Schöch, G
Published in Monatsschrift Kinderheilkunde (01.06.1987)
Get more information
Published in Monatsschrift Kinderheilkunde (01.06.1987)
Journal Article